ARCHIVES

PI Defends NCI’s National Lung Screening Trial As “Rigorous” Randomized Trial.

This article is from The Cancer Letter archive.

Vol. 32 No. 39 | November 3, 2006

Download PDF Visit The Full Archive

Related Articles

NSABP Protests NIH Rejection Of P-4 Appeal.

May 2, 2008

CGOP Gets New Life, Will Move T DCT; DCPC May Fund More CCOPs with Money It Saves

July 25, 1986

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Sixty CCOPs Could cost $16 Million; DCPC Staff Believes They Can Get It

October 10, 1986

Faulding, NaPro In Agreement For Marketing Paclitaxel.

March 30, 2001

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010